Incidence and risk factors for severe tardive dyskinesia in older patients

British Journal of Psychiatry

Volumn 171, Issue AUG., 1997, Pages 148-153

  Caligiuri, Michael P ^a,b   Lacro, Jonathan P ^a   Rockwell, Enid ^a   McAdams, Lou Ann ^a   Jeste, Dilip V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE MESILATE; HALOPERIDOL; NEUROLEPTIC AGENT; THIORIDAZINE;

ADULT; AGE; AGED; ARTICLE; BEHAVIOR DISORDER; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PSYCHOSIS; RISK FACTOR; TARDIVE DYSKINESIA;

EID: 0030844234     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.171.2.148     Document Type: Article

References (31)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn. revised) (DSM-III-R).Washington, DC: APA.
2. Asnis, G. M., Leopold, M. A., Duvoisin, R. C., et al (1977) A survey of tardive dyskinesia in psychiatric outpatients. American Journal of Psychiatry, 134, 1367-1370.
3. Barnes, T. R. E., Kidger, T. & Gore, S. M. (1983) Tardive dyskinesia: a 3-year follow-up study. Psychological Medicine, 13, 71-81.
4. Bergen, J. A., Eyland, E. A., Campbell, J. A., et al (1989) The course of tardive dyskinesia inpatients on long-term neuroleptics. British Journal of Psychiatry, 154, 523-528.
5. Brandon, S., McClelland, H. A. & Protheroe, C. (1971) A study of facial dyskinesia in a mental hospital population. British Journal of Psychiatry, 118, 171-184.
6. Caligiuri, M. P., Lohr, J. B., Bracha, H. S., et al (1991) Clinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia. Biological Psychiatry, 29, 139-148.
7. Cutler, S. J. & Ederer, F. (1958) Maximum utilization of the life table method in analyzing survival. Journal of Chronic Disorders, 8, 669-712.
8. Dixon, W. J. (1992) BMDP Statistical Software Manual (vols I & 2). Berkeley, CA: University of California Press.
9. Edwards, H. (1970) The significance of brain damage in persistent oral dyskinesia. British Journal of Psychiatry, 116, 271-275.
10. Folstein, M. F., Folstein, S. E. & McHugh, P. R. (1975) Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
11. Gardos, G., Cole, J. O., Salomon, M., et al (1987a) Clinical forms of severe tardive dyskinesia. American Journal of Psychiatry, 144, 895-902.
12. _, _, Schniebolk, S., et al (1987b) Comparison of severe and mild tardive dyskinesia: implications for etiology. Journal of Clinical Psychiatry, 48, 359-362.
13. Gimenez-Roldan, S., Mateo, D. & Bartolome, P. (1985) Tardive dystonia and severe tardive dyskinesia: a comparison of risk factors and prognosis. Acta Psychiatrica Scandinavica, 44, 417.
14. Guy, W., Ban, T. A. & Wilson, W. H. (1986) The prevalence of abnormal involuntary movements among chronic schizophrenics. International Clinical Psychopharmacology, 1, 134-144.
15. Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278-296.
16. Jeste, D. V., Calgiuri, M. P., Paulsen, J. S., et al (1995) Risk of tardive dyskinesia in older patients: a prospective longitudinal study of 266 patients. Archives of General Psychiatry, 52, 756-765.
17. Kane, J. M., Jeste, D. V., Barnes, T. R. E., et al (1992) Tardive Dyskinesia: A Task force Report of the American Psychaitric Association. Washington, DC: APA.
18. Lacro, J. P., Gilbert, P. L., Paulsen, J. S., et al (1994) Early course of new-onset tardive dyskinesia in older patients. Psychopharmacology Bulletin, 30, 187-191.
19. McCreadie, R. G., Barron, E. T. & Winslow, G. S. (1982) The Nithsdale schizophrenia survey II: abnormal movements. British Journal of Psychiatry, 140, 587-590.
20. Overall, J. E. & Gorham, D. R. (1962) The Brief Psychiatric Rating Scale. Psychological Reports, 10, 799-812.
21. Paulsen, J. S., Caligiuri, M. P., Palmer, B., et al (1996) Risk factors for orofacial and limbtruncal tardive dyskinesia in older patients: a prospective longitudinal study. Psychopharmocology, 123, 307-314.
22. Schooler, N. & Kane, J. M. (1982) Research diagnoses for tardive dyskinesia. Archives of General Psychiatry, 39, 486-487.
23. Simpson, G. M. & Angus, J. W. (1970) A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica Supplementum, 212, 11-19.
24. Smith, J. M., Kucharski, L. T., Oswald, W. T., et al (1979) Tardive dyskinesia: effects of age, sex, and criterion level of symptomatology on prevalence estimates. Psychopharmacology Bulletin, 15, 69-71.
25. Toenniessen, L. M., Casey, D. E. & McFarland, B. H. (1985) Tardive dyskinesia in the aged. Archives of General Psychiatry, 42, 278.
26. Waddington, J. L. (1995) Psychopathological and cognitive correlates of tardive dyskinesia in schizophrenia and other disorders treated with neuroleptic drugs. In Behavioral Neurology of Movement Disorders (eds W. J. Weiner & A. E. Lang), pp. 211-229. New York: Raven Press.
27. _ & Youssef, H. A. (1990) Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia. Psychological Medicine, 263, 681-688.
28. _, _, Molloy, A. G., et al (1985) Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies. Journal of Clinical Psychiatry, 46, 29-33.
29. Wojcik, J. D., Gelenberg, A. J., La Brie, R. A., et al (1980) Prevalence of tardive dyskinesia in an outpatient population. Comprehensive Psychiatry 21, 370-380.
30. Yassa, R. (1989) Functional impairment in tardive dyskinesia: medical and psychosocial dimensions. Acta Psychiatrica Scandinavica, 80, 64-67.
31. Yuen, O., Caligiuri, M. P., Williams, R., et al (1996) Tardive dyskinesia and positive and negative symptoms of schizophrenia: a study using instrumental measures. British Journal of Psychiatry, 168, 702-708.